Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samvel B Gasparyan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Circulation. Population Health and Outcomes|February 16, 2026
Characterizing Treatment Effects on Patient-Reported Outcomes in Heart Failure TrialsRobin Myte, Samvel B Gasparyan, Per Nyström
Circulation. Heart Failure|April 15, 2026
Response by Myte et al to Letter Regarding Article, "Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin"Robin Myte, Samvel B Gasparyan, Per Nyström
Clinical Trials (London, England)|November 14, 2022
The maraca plot: A novel visualization of hierarchical composite endpointsMartin Karpefors, Daniel Lindholm, Samvel B Gasparyan
Biometrical Journal. Biometrische Zeitschrift|May 23, 2026
The Univariate Distribution of Hierarchical Composite Endpoints and the Condorcet Non-transitivity ParadoxSamvel B Gasparyan, Gary G Koch, Edgar Brunner
Kidney International|September 20, 2025
The authors replyDustin J Little, Samvel B Gasparyan, Patrick Schloemer
Statistics in Medicine|June 17, 2022
Comments on "Sample size formula for a win ratio endpoint" by R. X. Yu and J. GanjuSamvel B Gasparyan, Elaine K Kowalewski, Gary G Koch
Statistical Methods in Medical Research|July 30, 2020
Adjusted win ratio with stratification: Calculation methods and interpretationSamvel B Gasparyan, Folke Folkvaljon, Olof Bengtsson, et al.
Kidney International|March 26, 2025
Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpointDustin J Little, Niels Jongs, Meike Brinker, et al.
Journal of Biopharmaceutical Statistics|September 23, 2021
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trialsSamvel B Gasparyan, Elaine K Kowalewski, Folke Folkvaljon, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2021
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' replyMikhail N Kosiborod, Russell Esterline, Jan Oscarsson, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Circulation. Population Health and Outcomes|February 16, 2026
Characterizing Treatment Effects on Patient-Reported Outcomes in Heart Failure TrialsRobin Myte, Samvel B Gasparyan, Per Nyström
Circulation. Heart Failure|April 15, 2026
Response by Myte et al to Letter Regarding Article, "Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin"Robin Myte, Samvel B Gasparyan, Per Nyström
Clinical Trials (London, England)|November 14, 2022
The maraca plot: A novel visualization of hierarchical composite endpointsMartin Karpefors, Daniel Lindholm, Samvel B Gasparyan
Biometrical Journal. Biometrische Zeitschrift|May 23, 2026
The Univariate Distribution of Hierarchical Composite Endpoints and the Condorcet Non-transitivity ParadoxSamvel B Gasparyan, Gary G Koch, Edgar Brunner
Kidney International|September 20, 2025
The authors replyDustin J Little, Samvel B Gasparyan, Patrick Schloemer
Statistics in Medicine|June 17, 2022
Comments on "Sample size formula for a win ratio endpoint" by R. X. Yu and J. GanjuSamvel B Gasparyan, Elaine K Kowalewski, Gary G Koch
Statistical Methods in Medical Research|July 30, 2020
Adjusted win ratio with stratification: Calculation methods and interpretationSamvel B Gasparyan, Folke Folkvaljon, Olof Bengtsson, et al.
Kidney International|March 26, 2025
Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpointDustin J Little, Niels Jongs, Meike Brinker, et al.
Journal of Biopharmaceutical Statistics|September 23, 2021
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trialsSamvel B Gasparyan, Elaine K Kowalewski, Folke Folkvaljon, et al.
The Lancet. Diabetes & Endocrinology|December 18, 2021
Dapagliflozin in patients with COVID-19: mind the kidneys - Authors' replyMikhail N Kosiborod, Russell Esterline, Jan Oscarsson, et al.
Pageof 3